Aurora Cannabis - ACB Stock Forecast, Price & News

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 5 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" ACB shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ACB, but not buy additional shares or sell existing shares.
View ACB analyst ratings or view top-rated stocks.

6 equities research analysts have issued 1 year price objectives for Aurora Cannabis' stock. Their ACB share price forecasts range from $1.00 to $3.90. On average, they anticipate the company's share price to reach $2.03 in the next year. This suggests a possible upside of 186.9% from the stock's current price.
View analysts price targets for ACB or view top-rated stocks among Wall Street analysts.

Aurora Cannabis' stock was trading at $0.9226 at the beginning of the year. Since then, ACB shares have decreased by 23.5% and is now trading at $0.7059.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our ACB earnings forecast.

Aurora Cannabis Inc. (NYSE:ACB) announced its quarterly earnings data on Thursday, February, 9th. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by $0.07. The business had revenue of $50.95 million for the quarter, compared to analyst estimates of $42.60 million. Aurora Cannabis had a negative net margin of 817.07% and a negative trailing twelve-month return on equity of 62.73%.

Global X Cannabis ETF holds 2,298,350 shares of ACB stock, representing 4.21% of its portfolio.

Aurora Cannabis shares reverse split on Monday, May 11th 2020. The 1-12 reverse split was announced on Friday, May 8th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, May 8th 2020. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Aurora Cannabis investors own include Cronos Group (CRON), NVIDIA (NVDA), Tilray (TLRY), Alibaba Group (BABA), Advanced Micro Devices (AMD), General Electric (GE) and Micron Technology (MU).

Aurora Cannabis trades on the New York Stock Exchange (NYSE) under the ticker symbol "ACB."

Aurora Cannabis' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Renaissance Technologies LLC (1.83%), Mirae Asset Global Investments Co. Ltd. (0.59%), Dimensional Fund Advisors LP (0.38%), Geode Capital Management LLC (0.23%), Swiss National Bank (0.22%) and K2 Principal Fund L.P. (0.17%).

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of ACB stock can currently be purchased for approximately $0.71.

Aurora Cannabis (NYSE:ACB) has a market capitalization of $241.51 million and generates $211.59 million in revenue each year. The company earns $-1,357,090,000.00 in net income (profit) each year or ($6.04) on an earnings per share basis.

The company employs 1,338 workers across the globe.

Aurora Cannabis' mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The official website for the company is auroramj.com. The company can be reached via phone at (855) 279-4652 or via email at ir@auroramj.com.